Episurf Medical AB (publ) (ST:EPIS-B) — Stock Price

Skr0.06 SEK
▼ -2.97% today

Episurf Medical AB (publ) (ST:EPIS-B) is currently trading at Skr0.06 SEK, down 2.97% today. Over the past 52 weeks, shares have ranged between Skr0.03 and Skr0.20. This page tracks Episurf Medical AB (publ)'s live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Episurf Medical AB (publ) (EPIS-B) total market value.

Episurf Medical AB (publ) (EPIS-B) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Episurf Medical AB (publ)'s daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Episurf Medical AB (publ) Income Statement — Revenue, Profit & Earnings by Year

Episurf Medical AB (publ)'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr13.50 Million Skr13.00 Million Skr10.30 Million Skr6.60 Million Skr6.50 Million
Cost of Revenue Skr57.50 Million Skr2.30 Million Skr104.40 Million Skr4.20 Million Skr4.80 Million
Gross Profit Skr-44.00 Million Skr10.70 Million Skr-94.10 Million Skr2.40 Million Skr1.70 Million
Research & Development Skr5.50 Million Skr8.30 Million Skr11.60 Million Skr6.90 Million
SG&A Skr10.90 Million Skr11.90 Million Skr21.40 Million Skr40.30 Million Skr33.90 Million
Total Operating Expenses Skr16.40 Million Skr87.90 Million Skr2.70 Million Skr79.40 Million Skr71.10 Million
Operating Income Skr-60.40 Million Skr-77.20 Million Skr-94.80 Million Skr-77.00 Million Skr-69.40 Million
EBITDA Skr-49.20 Million Skr-69.00 Million Skr-87.70 Million Skr-71.40 Million Skr-63.80 Million
EBIT Skr-57.30 Million Skr-75.00 Million Skr-96.40 Million Skr-76.50 Million Skr-69.10 Million
Interest Expense Skr600.00K Skr1.00 Million Skr900.00K Skr700.00K Skr200.00K
Income Before Tax Skr-58.00 Million Skr-76.00 Million Skr-94.60 Million Skr-77.20 Million Skr-69.20 Million
Income Tax Expense Skr300.00K Skr100.00K Skr200.00K Skr100.00K Skr300.00K
Net Income Skr-58.20 Million Skr-76.00 Million Skr-94.80 Million Skr-77.30 Million Skr-69.50 Million

Episurf Medical AB (publ) Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Episurf Medical AB (publ)'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr59.80 Million Skr97.80 Million Skr104.30 Million Skr197.20 Million Skr270.60 Million
Total Current Assets Skr17.70 Million Skr59.70 Million Skr65.00 Million Skr161.00 Million Skr244.40 Million
Cash & Equivalents
Short-term Investments
Net Receivables Skr5.50 Million Skr4.00 Million Skr1.40 Million Skr3.90 Million Skr4.50 Million
Inventory Skr3.00 Million Skr3.20 Million Skr3.70 Million Skr1.90 Million Skr1.90 Million
Property, Plant & Equipment Skr5.10 Million Skr2.80 Million Skr5.60 Million Skr6.70 Million Skr3.30 Million
Goodwill Skr21.50 Million
Total Liabilities Skr12.30 Million Skr14.00 Million Skr19.80 Million Skr19.50 Million Skr17.80 Million
Total Current Liabilities Skr10.40 Million Skr13.90 Million Skr17.40 Million Skr14.70 Million Skr14.20 Million
Long-term Debt
Net Debt Skr-300.00K Skr-48.20 Million Skr-52.70 Million Skr-149.00 Million Skr-235.00 Million
Total Stockholder Equity Skr47.50 Million Skr83.80 Million Skr84.50 Million Skr177.70 Million Skr252.80 Million
Retained Earnings Skr-813.70 Million Skr-755.10 Million Skr-680.20 Million Skr-587.00 Million Skr-511.30 Million

Episurf Medical AB (publ) Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Episurf Medical AB (publ) generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-55.30 Million Skr-71.40 Million Skr-84.80 Million Skr-69.50 Million Skr-59.70 Million
Capital Expenditures Skr55.30 Million Skr7.60 Million Skr9.50 Million Skr11.30 Million Skr7.00 Million
Free Cash Flow Skr-62.00 Million Skr-79.00 Million Skr-94.30 Million Skr-80.80 Million Skr-66.70 Million
Investing Cash Flow Skr-6.70 Million Skr-7.60 Million Skr-9.50 Million Skr-11.20 Million Skr-6.50 Million
Financing Cash Flow Skr18.60 Million Skr71.60 Million Skr-3.00 Million Skr-1.90 Million Skr149.20 Million
Dividends Paid
Stock-Based Compensation Skr300.00K Skr1.00 Million Skr700.00K Skr-200.00K Skr3.30 Million
Depreciation Skr8.10 Million Skr9.00 Million Skr6.00 Million Skr7.40 Million Skr7.40 Million
Change in Cash Skr-43.40 Million Skr-7.40 Million Skr-97.40 Million Skr-82.60 Million Skr82.90 Million

Episurf Medical AB (publ) Earnings History — EPS Actual vs. Analyst Estimates

Track Episurf Medical AB (publ)'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 04, 2026
Feb 06, 2026 -0.01
Oct 24, 2025 -0.01
Jul 11, 2025 -0.03
Apr 10, 2025 -0.03
Feb 07, 2025 -0.03
Oct 25, 2024 -0.02
Jul 12, 2024 -0.06